Skip to content

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test

Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test: Comparison of Biozek COVID-19 Antigen Rapid Test Results Performed on Self-collected Samples by the Subjects, to Results of COVID-19 RT-PCR as a Standard of Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04926779
Enrollment
185
Registered
2021-06-15
Start date
2021-05-24
Completion date
2022-11-04
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19 Testing

Keywords

Covid-19, Antigen, Rapid, Test

Brief summary

This is a research study to evaluate the Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test (Saliva) and BIOZEK COVID-19 Antigen Rapid Test (Nasopharyngeal Swab) on samples that are self-collected; and to perform analysis to compare results. In addition, to obtain RT-PCR test results, performed prior to enrollment, and compare all three results.

Interventions

DIAGNOSTIC_TESTBiozek Covid-19 Antigen Rapid Test (Saliva)

Self-collection of nasopharyngeal and saliva samples and self test performance - Biozek Covid-19 Antigen Rapid Test (Saliva) and Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab). Both procedures are supervised by trained study personnel.

Sponsors

Mach-E B.V.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must be ≥18 years of age and have had an RT-PCR test performed prior to enrollment. * Subjects must be able to understand and willingly sign a written informed consent. Additionally, participants need to meet at least 1 of the criteria listed below: * Currently experiencing symptoms of COVID-19. * Be clinically diagnosed or suspected to have COVID-19. * Recent past (3 weeks) exhibited symptoms of COVID-19. * Be capable of performing a self-collection of a nasopharyngeal sample with use of nasal swab kit. * Be capable of performing a self-collection of an oral fluid sample with use of oral fluid collection kit. * Interacted with a COVID-19 positive individual.

Exclusion criteria

Subjects who meet any of the following

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Saliva)6 monthsThe Biozek Antigen Rapid Tests performed by subjects on the self-collected, oral fluid samples . Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.
Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab)6 monthsThe Biozek Antigen Rapid Tests performed by subjects on the self-collected, nasopharyngeal samples . Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Countries

United States

Participant flow

Participants by arm

ArmCount
BIOZEK COVID-19 Antigen Rapid Test (Oral Fluid)
BIOZEK COVID-19 Antigen Rapid Test performed by subjects on self-collected, oral fluid samples compared to RT-PCR.
185
Total185

Baseline characteristics

CharacteristicBIOZEK COVID-19 Antigen Rapid Test (Oral Fluid)
Age, Customized
18-24 years
36 Participants
Age, Customized
25-64 years
128 Participants
Age, Customized
65-87 years
19 Participants
Age, Customized
Unknown
2 Participants
Race/Ethnicity, Customized
Arabic
1 Participants
Race/Ethnicity, Customized
Asian
12 Participants
Race/Ethnicity, Customized
Black
51 Participants
Race/Ethnicity, Customized
Caucasian
74 Participants
Race/Ethnicity, Customized
Hispanic/Latino
31 Participants
Race/Ethnicity, Customized
Indian
1 Participants
Race/Ethnicity, Customized
Native American
1 Participants
Race/Ethnicity, Customized
Pacific Islander
4 Participants
Race/Ethnicity, Customized
Unknown
10 Participants
Region of Enrollment
United States
185 participants
Sex: Female, Male
Female
111 Participants
Sex: Female, Male
Male
71 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 185
other
Total, other adverse events
0 / 185
serious
Total, serious adverse events
0 / 185

Outcome results

Primary

Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab)

The Biozek Antigen Rapid Tests performed by subjects on the self-collected, nasopharyngeal samples . Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Time frame: 6 months

ArmMeasureGroupValue (NUMBER)
BIOZEK COVID-19 Antigen Rapid Test (Oral Fluid)Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab)Sensitivity97.8 percentage - Sensitivity and specificity
BIOZEK COVID-19 Antigen Rapid Test (Oral Fluid)Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab)Specificity100 percentage - Sensitivity and specificity
Primary

Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Saliva)

The Biozek Antigen Rapid Tests performed by subjects on the self-collected, oral fluid samples . Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Time frame: 6 months

ArmMeasureGroupValue (NUMBER)
BIOZEK COVID-19 Antigen Rapid Test (Oral Fluid)Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Saliva)Sensitivity97.5 percentage - Sensitivity and specificity
BIOZEK COVID-19 Antigen Rapid Test (Oral Fluid)Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Saliva)Specifity100 percentage - Sensitivity and specificity

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026